Institutional Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$193M Sell
919,915
-285,509
-24% -$59.1M 2.86% 17
2016
Q3
$278M Sell
1,205,424
-331,814
-22% -$81.1M 3.83% 7
2016
Q2
$355M Buy
1,537,238
+44,876
+3% +$10.3M 4.35% 3
2016
Q1
$400M Sell
1,492,362
-173,914
-10% -$49.8M 4.25% 3
2015
Q4
$521M Sell
1,666,276
-461,256
-22% -$137M 4.51% 2
2015
Q3
$578M Buy
2,127,532
+310,518
+17% +$95.4M 4.83% 1
2015
Q2
$551M Buy
1,817,014
+235,450
+15% +$70.2M 3.86% 4
2015
Q1
$471M Buy
1,581,564
+1,367,167
+638% +$390M 2.9% 17
2014
Q4
$55.2M Buy
+214,397
New +$53.6M 0.33% 45

Other funds holding AGN

Institutional Capital's AGN Position: Q4 2016 in Review

Institutional Capital reduced its Allergan plc (AGN) stake by 24% in Q4 2016, selling an estimated $59.1M and leaving 919,915 shares worth $193M. The position accounts for 2.86% of the portfolio, ranked #17.

Institutional Capital first reported a position in AGN in Q4 2014 and has held it in 9 quarters since. The position peaked at $578M in Q3 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Institutional Capital held 919,915 shares of Allergan plc worth $193M as of Q4 2016.
  • Institutional Capital sold 285,509 Allergan plc shares in Q4 2016, an estimated $59.1M.
  • Allergan plc made up 2.86% of Institutional Capital's portfolio in Q4 2016, its #17 holding.
  • Institutional Capital first reported a position in Allergan plc in Q4 2014 and has held it in 9 quarters since.
  • Institutional Capital's Allergan plc position peaked at $578M in Q3 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Institutional Capital's 13F filing for Q4 2016, filed 2 Feb 2017.